Boronic acid compounds designed via a de novo library and virtual screening platform target the ClpP enzyme. The dataset likely contains results from a study identifying α-aminoboronic acids as inhibitors of human ClpXP, which degrades misfolded proteins. R.E. Lee from the University of Toronto authored this research, which is available under an Open Access license.
Use Cases
- Virtual screening of covalent ligands based on the described de novo library design.
- Identifying novel α-aminoboronic acid inhibitors based on the screening results.
- Studying enzyme inhibition mechanisms for ClpP and ClpXP proteases based on the described bioactive compounds.
Strengths
- Data originates from a described de novo library design and virtual screening platform.
- Research is associated with the University of Toronto and published under an Open Access license.
Limitations
- Column-level documentation is absent; field semantics must be inferred after download.
- Row count is unknown, which may limit suitability assessment.
- Last update date is unknown; freshness unverified.
Provenance
- Source
- University of Toronto
- Collection Method
- De novo library design and virtual screening for covalent ligands.